Clearly, the effect of celecoxib on iNOS, P-gp and BCRP expression in addition to what we have shown about its capacity to induce apoptosis in MDR1-positive cancer cells could be responsible for its reported anticancer effect 16,33,34. This evidence concerns the gene NOS2 and cancer.